Back to matchesWe found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleWhere Does Denosumab Stand in the Treatment of Glucocorticoid‐Induced Osteoporosis? Comment on the Article by Saag et al.AuthorsChattopadhyay, Arghya; Sharma, Shefali K.; Sharma, Aman; Jain, Sanjay; Dhir, VarunSubjectsDENOSUMAB; THERAPEUTIC use of monoclonal antibodies; BONE fractures; GLUCOCORTICOIDS; IMMUNE system; MONOCLONAL antibodies; OSTEOPOROSIS; PATIENT safety; TREATMENT effectiveness; RISEDRONATE; DISEASE risk factors; EVALUATIONPublicationArthritis & Rheumatology, 2019, Vol 71, Issue 10, p1770ISSN2326-5191Publication typeLetter to the EditorDOI10.1002/art.41015